This report aims to provide a comprehensive presentation of the global market for Peripheral Arterial Disease (PAD) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Arterial Disease (PAD) Drugs. This report contains market size and forecasts of Peripheral Arterial Disease (PAD) Drugs in global, including the following market information:
- Global Peripheral Arterial Disease (PAD) Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
The global Peripheral Arterial Disease (PAD) Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Clopidogrel (Plavix) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peripheral Arterial Disease (PAD) Drugs include AstraZeneca (UK), Bayer HealthCare Pharmaceuticals (Germany), Bristol-Myers Squibb Company (US), Merck & Co (US), Proteon Therapeutics (US), Sanofi (France), Symic Bio (US) and TheraVasc (US), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peripheral Arterial Disease (PAD) Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripheral Arterial Disease (PAD) Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Peripheral Arterial Disease (PAD) Drugs Market Segment Percentages, by Type, 2022 (%)
- Clopidogrel (Plavix)
- Prasugrel (Effient)
- Ticagrelor (Brilinta)
- Vorapaxar (Zontivity)
- Others
Global Peripheral Arterial Disease (PAD) Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Peripheral Arterial Disease (PAD) Drugs Market Segment Percentages, by Application, 2022 (%)
Global Peripheral Arterial Disease (PAD) Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Peripheral Arterial Disease (PAD) Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Peripheral Arterial Disease (PAD) Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Peripheral Arterial Disease (PAD) Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AstraZeneca (UK)
- Bayer HealthCare Pharmaceuticals (Germany)
- Bristol-Myers Squibb Company (US)
- Merck & Co (US)
- Proteon Therapeutics (US)
- Sanofi (France)
- Symic Bio (US)
- TheraVasc (US)
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Peripheral Arterial Disease (PAD) Drugs, market overview.
- Chapter 2: Global Peripheral Arterial Disease (PAD) Drugs market size in revenue.
- Chapter 3: Detailed analysis of Peripheral Arterial Disease (PAD) Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Peripheral Arterial Disease (PAD) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peripheral Arterial Disease (PAD) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Arterial Disease (PAD) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Arterial Disease (PAD) Drugs Overall Market Size
2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size: 2022 VS 2029
2.2 Global Peripheral Arterial Disease (PAD) Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peripheral Arterial Disease (PAD) Drugs Players in Global Market
3.2 Top Global Peripheral Arterial Disease (PAD) Drugs Companies Ranked by Revenue
3.3 Global Peripheral Arterial Disease (PAD) Drugs Revenue by Companies
3.4 Top 3 and Top 5 Peripheral Arterial Disease (PAD) Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peripheral Arterial Disease (PAD) Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Players in Global Market
3.6.1 List of Global Tier 1 Peripheral Arterial Disease (PAD) Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripheral Arterial Disease (PAD) Drugs Market Size Markets, 2022 & 2029
4.1.2 Clopidogrel (Plavix)
4.1.3 Prasugrel (Effient)
4.1.4 Ticagrelor (Brilinta)
4.1.5 Vorapaxar (Zontivity)
4.1.6 Others
4.2 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
4.2.1 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2023
4.2.2 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2024-2029
4.2.3 By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Arterial Disease (PAD) Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
5.2.1 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2023
5.2.2 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2024-2029
5.2.3 By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Peripheral Arterial Disease (PAD) Drugs Market Size, 2022 & 2029
6.2 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue & Forecasts
6.2.1 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2023
6.2.2 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2024-2029
6.2.3 By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2029
6.3.2 US Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.3.3 Canada Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.3.4 Mexico Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2029
6.4.2 Germany Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4.3 France Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4.4 U.K. Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4.5 Italy Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4.6 Russia Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.4.8 Benelux Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2029
6.5.2 China Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.5.3 Japan Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.5.4 South Korea Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.5.6 India Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2029
6.6.2 Brazil Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.6.3 Argentina Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2029
6.7.2 Turkey Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.7.3 Israel Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
6.7.5 UAE Peripheral Arterial Disease (PAD) Drugs Market Size, 2018-2029
7 Peripheral Arterial Disease (PAD) Drugs Companies Profiles
7.1 AstraZeneca (UK)
7.1.1 AstraZeneca (UK) Company Summary
7.1.2 AstraZeneca (UK) Business Overview
7.1.3 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.1.4 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca (UK) Key News & Latest Developments
7.2 Bayer HealthCare Pharmaceuticals (Germany)
7.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Summary
7.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
7.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.2.4 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.2.5 Bayer HealthCare Pharmaceuticals (Germany) Key News & Latest Developments
7.3 Bristol-Myers Squibb Company (US)
7.3.1 Bristol-Myers Squibb Company (US) Company Summary
7.3.2 Bristol-Myers Squibb Company (US) Business Overview
7.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Company (US) Key News & Latest Developments
7.4 Merck & Co (US)
7.4.1 Merck & Co (US) Company Summary
7.4.2 Merck & Co (US) Business Overview
7.4.3 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.4.4 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck & Co (US) Key News & Latest Developments
7.5 Proteon Therapeutics (US)
7.5.1 Proteon Therapeutics (US) Company Summary
7.5.2 Proteon Therapeutics (US) Business Overview
7.5.3 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.5.4 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.5.5 Proteon Therapeutics (US) Key News & Latest Developments
7.6 Sanofi (France)
7.6.1 Sanofi (France) Company Summary
7.6.2 Sanofi (France) Business Overview
7.6.3 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.6.4 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.6.5 Sanofi (France) Key News & Latest Developments
7.7 Symic Bio (US)
7.7.1 Symic Bio (US) Company Summary
7.7.2 Symic Bio (US) Business Overview
7.7.3 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.7.4 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.7.5 Symic Bio (US) Key News & Latest Developments
7.8 TheraVasc (US)
7.8.1 TheraVasc (US) Company Summary
7.8.2 TheraVasc (US) Business Overview
7.8.3 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Major Product Offerings
7.8.4 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue in Global Market (2018-2023)
7.8.5 TheraVasc (US) Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peripheral Arterial Disease (PAD) Drugs Market Opportunities & Trends in Global Market
Table 2. Peripheral Arterial Disease (PAD) Drugs Market Drivers in Global Market
Table 3. Peripheral Arterial Disease (PAD) Drugs Market Restraints in Global Market
Table 4. Key Players of Peripheral Arterial Disease (PAD) Drugs in Global Market
Table 5. Top Peripheral Arterial Disease (PAD) Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peripheral Arterial Disease (PAD) Drugs Product Type
Table 9. List of Global Tier 1 Peripheral Arterial Disease (PAD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peripheral Arterial Disease (PAD) Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca (UK) Company Summary
Table 31. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 32. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca (UK) Key News & Latest Developments
Table 34. Bayer HealthCare Pharmaceuticals (Germany) Company Summary
Table 35. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 36. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer HealthCare Pharmaceuticals (Germany) Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company (US) Company Summary
Table 39. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 40. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Company (US) Key News & Latest Developments
Table 42. Merck & Co (US) Company Summary
Table 43. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 44. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co (US) Key News & Latest Developments
Table 46. Proteon Therapeutics (US) Company Summary
Table 47. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 48. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Proteon Therapeutics (US) Key News & Latest Developments
Table 50. Sanofi (France) Company Summary
Table 51. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 52. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Sanofi (France) Key News & Latest Developments
Table 54. Symic Bio (US) Company Summary
Table 55. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 56. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Symic Bio (US) Key News & Latest Developments
Table 58. TheraVasc (US) Company Summary
Table 59. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Product Offerings
Table 60. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. TheraVasc (US) Key News & Latest Developments
List of Figures
Figure 1. Peripheral Arterial Disease (PAD) Drugs Segment by Type in 2022
Figure 2. Peripheral Arterial Disease (PAD) Drugs Segment by Application in 2022
Figure 3. Global Peripheral Arterial Disease (PAD) Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peripheral Arterial Disease (PAD) Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Peripheral Arterial Disease (PAD) Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2022
Figure 8. By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 16. US Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 28. China Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Peripheral Arterial Disease (PAD) Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
